{"id":970996,"date":"2026-06-05T07:03:15","date_gmt":"2026-06-05T11:03:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/"},"modified":"2026-06-05T07:03:15","modified_gmt":"2026-06-05T11:03:15","slug":"foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/","title":{"rendered":"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., June  05, 2026  (GLOBE NEWSWIRE) &#8212; Foghorn<sup>\u00ae<\/sup> Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Goldman Sachs 47<sup>th<\/sup> Annual Global Healthcare Conference 2026. With an initial focus in oncology, Foghorn\u2019s Gene Traffic Control<sup>\u00ae<\/sup>\u00a0platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.<\/p>\n<p>\n        <strong>Goldman Sachs 47th Annual Global Healthcare Conference 2026<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:6pt;margin-bottom:12pt\">Fireside Chat: Tuesday, June 9, 2026, at 1:20 p.m. EDT<\/li>\n<li>Presenter: Adrian Gottschalk, President and Chief Executive Officer<\/li>\n<li>Registration link: <a href=\"https:\/\/event.webcasts.com\/starthere.jsp?ei=1766425&amp;tp_key=d08a8cfafb&amp;tp_special=8\" rel=\"nofollow\" target=\"_blank\">Register here<\/a><\/li>\n<li>Management will also participate in one-on-one meetings<\/li>\n<\/ul>\n<p>A webcast of the fireside chat can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the Company\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eNJrkUg_XyRzQWxvJhD64Tq8O6JsTogAyRw7pHF4C0cZk7PDGy8oDfYCFHFoAeVpUQXU8KASf18Fuscjrs8A380ofJlegY4fvVkVxenysIPZthrD2j1MAXFFB3u62d5q\" rel=\"nofollow\" target=\"_blank\">here<\/a> and will be available for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About Foghorn Therapeutics<\/strong><br \/>\n        <br \/>Foghorn<sup>\u00ae<\/sup> Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control<sup>\u00ae<\/sup> platform, Foghorn is systematically studying, identifying, and validating potential drug targets within the chromatin regulatory system. The Company is developing multiple product candidates in oncology. Visit our website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CAEtPA0diBMLsZpA_tqitiuIdM19SSIijyJiBR53sNp8r7SEwvSPC9wK5oDgmPFnawV8epyXJ9VAloId0ZZnxaT0cSGOphaSwidQa4lKe1dCzdvugErX46HeKbUrzkrkHTmS_rMLzK0tDNSHbhLazK8Cx_sHuO4zCgMWrFLuYBznwkoQZjzqELPT3_NlrI5aGhhKXtvG-1midP6vslXPZvBT-MQSCClrzkYQbblA4I0GEd7yAF36Dyjo5qhLsCC0Z9OXtMEmQPuRY1KFe4rLrQ==\" rel=\"nofollow\" target=\"_blank\">www.foghorntx.com<\/a>\u00a0for more information on the Company, and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rlqXr8xBYiCzsimu3WnrJYozh1t5ia_PDGWqx5o7Knl_rFVAH2M5UCL-Qc_W7qDtLoWnZ1ysbnmgL7hHpyufwdV8e9HbqQfdgTsvjeIP093Zw30fqFI5l8bY18IH2HgzGVDykQ36U7cDLj1Ph0jQ6xaK2MJ7ZiS45AK4wfN0MvD47MUHbnHCzFoZhgeW-v1m5W_jwdwe-c1ibv19psYFsg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cHbYuWZG_BDpF7bcbm-1ulC98mlyBymwm16NxWQXR7B47erAxm7OqR51OiJW7owcCiExVyZrTGuAMHsGNozlWsrv8hD9jnSuHKs5L0iHonCqj14yi-84QMDimrCpaM-G2rwMuTwgYNUu9Z3p1p1pDvsc4x0_zW8P5R8RDOx4h8b-DWbEhnHDoey3oIcatkeo14zyzWmAf-gMwcUmrjP4zfbsCm1tzorQij7d8wPkLRCFi_-RXCTlu3OjHw6pjIFN9npZrMPTl_S3pGJNENXPIQ==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Karin Hellsvik, Foghorn Therapeutics Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=44KTjdtdF9bvh4pBEInAsKeVBGuWgo0qSsbUQLUmlkJuVbR2QgQ5kkclCGJfGzfySt6H3vHvMGjynr53bzY1NzEZUuu-8zGUsRJAFUeJdGE=\" rel=\"nofollow\" target=\"_blank\"><u>khellsvik@foghorntx.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGMzYTIzYmUtNzNiZC00NWQwLTgxMzEtODA5NTFmYjYyNGE4LTEyMTQ0MTUtMjAyNi0wNi0wNS1lbg==\/tiny\/Foghorn-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., June 05, 2026 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026. With an initial focus in oncology, Foghorn\u2019s Gene Traffic Control\u00ae\u00a0platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases. Goldman Sachs 47th Annual Global Healthcare Conference 2026 Fireside Chat: Tuesday, June 9, 2026, at 1:20 p.m. EDT Presenter: Adrian Gottschalk, President and Chief Executive Officer Registration link: Register here Management will also participate in one-on-one meetings A webcast of the fireside &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-970996","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., June 05, 2026 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026. With an initial focus in oncology, Foghorn\u2019s Gene Traffic Control\u00ae\u00a0platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases. Goldman Sachs 47th Annual Global Healthcare Conference 2026 Fireside Chat: Tuesday, June 9, 2026, at 1:20 p.m. EDT Presenter: Adrian Gottschalk, President and Chief Executive Officer Registration link: Register here Management will also participate in one-on-one meetings A webcast of the fireside &hellip; Continue reading &quot;Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-05T11:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026\",\"datePublished\":\"2026-06-05T11:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/\",\"name\":\"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=\",\"datePublished\":\"2026-06-05T11:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/","og_locale":"en_US","og_type":"article","og_title":"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Market Newsdesk","og_description":"WATERTOWN, Mass., June 05, 2026 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026. With an initial focus in oncology, Foghorn\u2019s Gene Traffic Control\u00ae\u00a0platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases. Goldman Sachs 47th Annual Global Healthcare Conference 2026 Fireside Chat: Tuesday, June 9, 2026, at 1:20 p.m. EDT Presenter: Adrian Gottschalk, President and Chief Executive Officer Registration link: Register here Management will also participate in one-on-one meetings A webcast of the fireside &hellip; Continue reading \"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-05T11:03:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026","datePublished":"2026-06-05T11:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/","name":"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=","datePublished":"2026-06-05T11:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMjA0NyM3NjM3MTM2IzIyMDI4NjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=970996"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970996\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=970996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=970996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=970996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}